Hypoalbuminemia and cisplatin-induced acute kidney injury
Through meta-analysis and dual-center real-world data studies, we confirmed that hypoalbuminemia is an independent risk factor for CIA. Therefore, it is recommended that patients using cisplatin undergo serum albumin level testing and regular monitoring during treatment. Actively adjusting albumin levels may reduce the risk of CIA.
Authors
- Chien‐Hung Lai (ORCID: https://orcid.org/0000-0002-5765-3120)
- Xiaoqing Lin (ORCID: https://orcid.org/0000-0002-1690-136X)
- Xiao‐cong Zuo (ORCID: https://orcid.org/0000-0002-0294-6268)
- Qian-Qian Yu (ORCID: https://orcid.org/0000-0003-1772-3195)
- Hai‐long Piao (ORCID: https://orcid.org/0000-0001-7451-0386)
- Guangliang Zhou
- Lingyun Zhou (ORCID: https://orcid.org/0000-0002-8506-856X)
- Qing Zhu
- Kun Liu (ORCID: https://orcid.org/0000-0001-7242-1574)
- Yujie Huang (ORCID: https://orcid.org/0000-0003-4152-6896)
- Wenjun Yin (ORCID: https://orcid.org/0009-0005-3456-6867)
- Shanru Zuo
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.3389/fphar.2024.1510477
- Citations
- 2
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- National Natural Science Foundation of China